KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Current Leases (2021 - 2022)

Palvella Therapeutics (PVLA) has disclosed Current Leases for 4 consecutive years, with $12.3 million as the latest value for Q3 2023.

  • On a quarterly basis, Current Leases rose 1388.14% to $12.3 million in Q3 2023 year-over-year; TTM through Sep 2023 was $12.3 million, a 1388.14% increase, with the full-year FY2022 number at $859000.0, down 18.11% from a year prior.
  • Current Leases was $12.3 million for Q3 2023 at Palvella Therapeutics, up from $910000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $12.3 million in Q3 2023 to a low of $733000.0 in Q4 2019.
  • A 4-year average of $2.5 million and a median of $890000.0 in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: decreased 18.11% in 2022, then surged 1388.14% in 2023.
  • Palvella Therapeutics' Current Leases stood at $733000.0 in 2019, then soared by 43.11% to $1.0 million in 2021, then fell by 18.11% to $859000.0 in 2022, then soared by 1330.97% to $12.3 million in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Current Leases are $12.3 million (Q3 2023), $910000.0 (Q2 2023), and $890000.0 (Q1 2023).